miR-122 overexpression induces autophagy via PKM2 downregulation in Non-alcoholic fatty liver disease
نویسندگان
چکیده
Background and Aim: Non-alcoholic Fatty Liver Disease (NAFLD) is a significant global health concern, causing chronic liver disease. miR-122, microRNA abundant in the liver, found to be downregulated various cancers, including hepatocellular carcinoma (HCC). PKM2, variant of Pyruvate Kinase (PK), has been implicated HCC development due its high expression tumor tissues. PKM2 overexpression causes inflammation inhibits autophagy apoptosis cancer cells. Since miR-122 targets inhibiting could potentially downregulate NAFLD induce autophagy, making potential target for treatment. Methods: C57BL/6 mice were fed control, choline sufficient L-amino acid (CSAA), or deficient (CDAA) diets. After 6, 18, 32, 54 weeks, euthanized, tissues homogenized analyzed changes markers (Atg7, Beclin-1, LC3B) using RT-PCR Western blotting. HepG2 cells treated with free fatty acids regulation determined. The overexpressing knocked down Results: results mouse model showed that CDAA diet led downregulation expression, upregulation (p<0.05), (p<0.05). In FFAs, was increased, while significantly decreased Overexpressing resulted two-fold (p<0.05) increase markers. Moreover, similar as above. Conclusion: These findings confirmed leads increased enhancing autophagy. This suggests targeting novel approach regulate progression prevent HCC.
منابع مشابه
Autophagy and Non-Alcoholic Fatty Liver Disease
Autophagy, or cellular self-digestion, is a catabolic process that targets cell constituents including damaged organelles, unfolded proteins, and intracellular pathogens to lysosomes for degradation. Autophagy is crucial for development, differentiation, survival, and homeostasis. Important links between the regulation of autophagy and liver complications associated with obesity, non-alcoholic ...
متن کاملAssociation of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of diseases from simple steatosis to non-alcoholic steatohepatitis, with approximately 20% risk of progressing to fibrosis and cirrhosis. The aim of this study was to compare the relative expression levels of circulating miR-21, miR-34a, miR-122, miR-125b and miR-375 between healthy controls and NAFLD patients, and to assess the feasib...
متن کاملNon-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease describes a range of conditions caused by a build-up of fat within liver cells. It is very common and in many cases is linked to being obese or overweight. Most people with non-alcoholic fatty liver disease do not develop serious liver problems. In some people, the build-up of fat in the liver can lead to serious liver disease. However, all people with non-alco...
متن کاملNon-Alcoholic Fatty Liver Disease
Results: The term “non-alcoholic fatty liver disease” covers cases of a wide spectrum of severity, ranging from bland fatty liver without any inflammation and with little or no tendency to progress all the way to non-alcoholic steato hepatitis (NASH) with inflammatory reactions and hepatocyte damage, with or without fibrosis. Some 5% to 20% of patients with NAFLD develop NASH, which undergoes a...
متن کاملNon-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease describes a range of conditions caused by a build-up of fat within liver cells. It is very common and in many cases is linked to being obese or overweight. Most people with non-alcoholic fatty liver disease do not develop serious liver problems. In some people, the build-up of fat in the liver can lead to serious liver disease. However, all people with non-alco...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of clinical and experimental hepatology
سال: 2023
ISSN: ['0973-6883', '2213-3453']
DOI: https://doi.org/10.1016/j.jceh.2023.07.036